PL4009983T3 - Cholecalciferol for use in the treatment of celiac disease - Google Patents
Cholecalciferol for use in the treatment of celiac diseaseInfo
- Publication number
- PL4009983T3 PL4009983T3 PL20761900.8T PL20761900T PL4009983T3 PL 4009983 T3 PL4009983 T3 PL 4009983T3 PL 20761900 T PL20761900 T PL 20761900T PL 4009983 T3 PL4009983 T3 PL 4009983T3
- Authority
- PL
- Poland
- Prior art keywords
- cholecalciferol
- treatment
- celiac disease
- celiac
- disease
- Prior art date
Links
- 208000015943 Coeliac disease Diseases 0.000 title 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 title 1
- 235000005282 vitamin D3 Nutrition 0.000 title 1
- 239000011647 vitamin D3 Substances 0.000 title 1
- 229940021056 vitamin d3 Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Noodles (AREA)
- Confectionery (AREA)
- Seasonings (AREA)
- Alcoholic Beverages (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dairy Products (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Grain Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102019000014550A IT201900014550A1 (en) | 2019-08-09 | 2019-08-09 | USE OF CHOLECALCIFEROL AS AN ACTIVE AGENT IN THE TREATMENT OF CELIACIA |
| PCT/IB2020/057316 WO2021028772A1 (en) | 2019-08-09 | 2020-08-03 | Cholecalciferol for use in the treatment of celiac disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4009983T3 true PL4009983T3 (en) | 2024-10-28 |
Family
ID=69024537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20761900.8T PL4009983T3 (en) | 2019-08-09 | 2020-08-03 | Cholecalciferol for use in the treatment of celiac disease |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220273676A1 (en) |
| EP (1) | EP4009983B1 (en) |
| JP (1) | JP7610580B2 (en) |
| CN (1) | CN114269349A (en) |
| ES (1) | ES2988284T3 (en) |
| HU (1) | HUE068650T2 (en) |
| IT (1) | IT201900014550A1 (en) |
| PL (1) | PL4009983T3 (en) |
| PT (1) | PT4009983T (en) |
| WO (1) | WO2021028772A1 (en) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6214373B1 (en) * | 1999-10-07 | 2001-04-10 | Snowden-Sutton Associates, Inc. | Nutritional composition for treating inflammatory bowel diseases |
| WO2004001020A2 (en) | 2002-06-19 | 2003-12-31 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Methods and means to promote gut absorption |
| US9084434B2 (en) | 2006-09-27 | 2015-07-21 | Little Calumet Holdings Llc | Probiotic oral dosage forms |
| US20110052707A1 (en) * | 2008-02-12 | 2011-03-03 | Neil Robert Buck | Combination of vitamin d and 25-hydroxyvitamin d 3 |
| ES2691301T3 (en) * | 2010-03-12 | 2018-11-26 | Compagnie Gervais Danone | Lactic acid bacteria for celiac disease |
| US8128971B1 (en) * | 2010-06-15 | 2012-03-06 | Jack Wesley Wise | Method and formula for treating celiac disease |
| US8703218B2 (en) * | 2011-06-20 | 2014-04-22 | Enteral Health And Nutrition, Llc | Chocolate having cholecalciferol and method for forming |
| JP2016535037A (en) | 2013-10-28 | 2016-11-10 | ネステク ソシエテ アノニム | Monoacylglycerol and fat-soluble nutrients for use in the treatment of malabsorption with a non-mechanical basis |
| US9439913B1 (en) * | 2013-11-15 | 2016-09-13 | MVW Nutritionals, Inc. | Fat-soluble vitamin formulations |
| WO2015154010A1 (en) * | 2014-04-04 | 2015-10-08 | Perrow Wendy | Methods of treating celiac disease with larazotide |
| EP3328390B1 (en) * | 2015-07-12 | 2021-09-29 | CFSO GmbH | Lysine salts of cholecalciferol sulfate and their use for the treatment of vitamin d3 deficiency |
| KR20170026241A (en) * | 2015-08-28 | 2017-03-08 | 김병용 | Complex preparation for oral use |
| CN110177561B (en) * | 2017-01-12 | 2023-09-12 | 普罗比公司 | Probiotic compositions and their uses |
| WO2019004984A2 (en) * | 2017-05-29 | 2019-01-03 | Biofarma Ilac Sanayi Ve Ticaret A.S. | A pharmaceutical formulation comprising cholecalciferol |
| CN108294318A (en) | 2018-03-02 | 2018-07-20 | 武汉华康臣生物科技有限公司 | It is a kind of weight-reducing and control body weight functional food |
| CN108497184A (en) | 2018-03-12 | 2018-09-07 | 沈阳美神农牧科技有限公司 | A kind of concentrated feed promoting weaned piglet transitional period intestinal growth |
| IT202100007655A1 (en) * | 2021-03-29 | 2022-09-29 | Abiogen Pharma Spa | USE OF COLECALCIFEROL AS AN ADJUVANT IN THE TREATMENT OF MUSCULAR DYSTROPHIES |
-
2019
- 2019-08-09 IT IT102019000014550A patent/IT201900014550A1/en unknown
-
2020
- 2020-08-03 CN CN202080056294.3A patent/CN114269349A/en active Pending
- 2020-08-03 HU HUE20761900A patent/HUE068650T2/en unknown
- 2020-08-03 WO PCT/IB2020/057316 patent/WO2021028772A1/en not_active Ceased
- 2020-08-03 PL PL20761900.8T patent/PL4009983T3/en unknown
- 2020-08-03 EP EP20761900.8A patent/EP4009983B1/en active Active
- 2020-08-03 ES ES20761900T patent/ES2988284T3/en active Active
- 2020-08-03 JP JP2022507771A patent/JP7610580B2/en active Active
- 2020-08-03 US US17/632,841 patent/US20220273676A1/en active Pending
- 2020-08-03 PT PT207619008T patent/PT4009983T/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4009983A1 (en) | 2022-06-15 |
| JP2022544183A (en) | 2022-10-17 |
| CN114269349A (en) | 2022-04-01 |
| HUE068650T2 (en) | 2025-01-28 |
| PT4009983T (en) | 2024-09-09 |
| IT201900014550A1 (en) | 2021-02-09 |
| JP7610580B2 (en) | 2025-01-08 |
| EP4009983B1 (en) | 2024-06-12 |
| US20220273676A1 (en) | 2022-09-01 |
| ES2988284T3 (en) | 2024-11-19 |
| WO2021028772A1 (en) | 2021-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276217A (en) | Use of cannabinoids in the treatment of epilepsy | |
| GB201902427D0 (en) | Use of cannabinoids in the treatment of epilepsy | |
| IL290415A (en) | Deuterated compounds for use in the treatment of cancer | |
| GB201819573D0 (en) | Use of cannabinoids in the treatment of epilepsy | |
| IL279260A (en) | Kdm1a inhibitors for the treatment of disease | |
| LT3806898T (en) | Gremlin-1 antagonist for use in the treatment of cancer | |
| IL286000A (en) | Esketamine for the treatment of depression | |
| IL283948A (en) | Methods for the treatment of depression | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| GB201808575D0 (en) | Methods for the treatment of psoriatic arthrits | |
| IL284032A (en) | 3β-(benzyloxy)-17α-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders | |
| GB201914296D0 (en) | Treatment | |
| GB201918404D0 (en) | Compounds and their use for the treatment of aplha1-antitrypsin deficiency | |
| IL269121A (en) | Usl-311 for use in the treatment of cancer | |
| GB201912365D0 (en) | Treatment | |
| PT4009983T (en) | Cholecalciferol for use in the treatment of celiac disease | |
| IL291626A (en) | Treatment of celiac disease | |
| IL286533A (en) | Compounds for use in the treatment of adcy5-related dyskinesia | |
| ZA202001435B (en) | Abx196 for use in the treatment of bladder cancer | |
| GB201902579D0 (en) | Treatment | |
| HK40074743A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| HK40044464A (en) | R-fadrozole for use in the treatment of aldostonerism | |
| IL284074A (en) | Decorin for use in the treatment of diabetes | |
| GB201912760D0 (en) | Treatment | |
| GB201912335D0 (en) | Treatment |